To help pharmaceutical manufacturers to comply with DSCSA Saleable Returns requirements and learn how Smith Drug Company resolves saleable returns verification issues (specifically the negative verification responses), LSPediA now has…
Learn More
To help pharmaceutical manufacturers to comply with DSCSA Saleable Returns requirements and learn how Smith Drug Company resolves saleable returns verification issues (specifically the negative verification responses), LSPediA now has…
Join this supplier webcast from Smith Drug Company about the recent supplier communication letter for resolving saleable returns verification issues, specifically the negative verification responses, to meet the DSCSA Saleable…
Farmington Hills, MI – March 4, 2020 – LSPediA today announced the company has successfully completed the FDA DSCSA Pilot Program Project for Router Service Solution for Verification/Notification and Interoperability…
The November saleable returns deadline requires wholesale distributors to verify every saleable return package before restocking and the manufacturers must respond to a wholesalers’ request within 24 hours. The wholesalers,…